Lv3
278 积分 2023-04-25 加入
Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval, 1992-2021
1小时前
已完结
A meta-analysis of the impact of pharmacist interventions on clinical outcomes in patients with type-2 diabetes
4天前
已完结
Two Birds With One Stone: The Protective Role of the Antidiabetic Drug Sodium‐Glucose Cotransporter‐2 Inhibitor in Neurodegenerative Diseases
4天前
已完结
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
18天前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
18天前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
18天前
已完结
GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes
19天前
已完结
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
19天前
已完结
New Drugs Approved in 2020
28天前
已关闭
By the Numbers: Novel drugs approved by the FDA, 2011–2020
28天前
已关闭
皖公网安备34019202002308
